ORTEXORTEX News
Live short interest, options flow, and signals — free on ORTEX.Sign up free →
Market Commentary

I have comprehensive data from both universes. Let me now compile the key confirmed earnings events (type = "Earnings") for the week, focusing on the most notable names.

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 1 min read

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

I have comprehensive data from both universes. Let me now compile the key confirmed earnings events (type = "Earnings") for the week, focusing on the most notable names.

Heavy Week: Big Names In The Queue

Over 1,800 companies report this week. The calendar is packed from Monday through Friday with major names across financials, tech, and consumer sectors.

Today (Monday, May 4), Loews Corporation and CNA Financial kick off US earnings. National Australia Bank reports pre-market with a $88bn market cap in focus. Europe's Thales, the French defence giant, also drops numbers today — timely given elevated defence spending globally.

Tuesday and Wednesday bring a surge of industrial and financial names. Belimo Holding, the Swiss HVAC controls maker, posts results mid-week. European insurer and conglomerate results follow throughout the week.

Later in the week, the pace stays brisk. More than 1,800 companies across US/Canada and Europe combined report before Friday's close — one of the busiest stretches of the Q1 2026 season.

On the IPO front, no new listings are confirmed in the pipeline for the next seven days. The primary market remains quiet.

Watch Loews closely — the conglomerate's results often signal broader trends across insurance, energy, and hospitality sectors in a single report.

How this article was generated

Generated
3 May 2026, 16:31
Prompt version
migrated
Data sources
EarningsAlt DataIndex Rebalance

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.